Allscripts acquires patient engagement platform HealthGrid for $60M cash

Business executives shaking hands
Allscripts has acquired HealthGrid for $60 million cash. (Getty/Martin Barraud)

Allscripts has added a new mobile patient engagement platform to its existing suite of services with the acquisition of HealthGrid. 

The EHR vendor agreed to purchase HealthGrid for $60 million in cash, plus $50 million in earnout payments based on certain revenue targets, the company announced in a Securities and Exchange Commission filing on Thursday.

HealthGrid, which services more than 15,000 healthcare providers and more than 350 hospitals, focuses on improving patient-clinician interactions. Allscripts plans to "tightly integrate" HealthGrid into its FollowMyHealth portfolio, Allscripts CEO Paul Black said on an earnings call. He added that the shift toward value-based care requires a new approach to patient interactions. 

Featured Webinar

Reducing barriers to patient care: A cross-industry collaboration

Optum will bring together cross-industry experts to share a case study detailing how an employer, provider, payer and pharmaceutical company worked together to address migraines, a hard-to-diagnose condition. Learn how this team started with a model to risk stratify, predict undiagnosed, misdiagnosed and mismanaged members and how those analytics were used to enrich engagement for treatment and diagnosis optimization.

The company expects to close the acquisition by the end of the second quarter.

RELATED: Allscripts offered to buy Practice Fusion for $250M. A DOJ investigation changed everything

HealthGrid has grown significantly over the last several years. The company reported a 70% increase in revenue growth in 2017 versus the previous year and expects similar growth in 2018. 

For Allscripts, the deal continues a spree of acquisitions over the last year that included Practice Fusion and McKesson.

The announcement came as Allscripts issued its first-quarter earnings results. The company reported a 24% increase in revenue backed by $304 million in bookings.

Suggested Articles

A New Jersey medical office has filed suit against Cigna, alleging that the insurer failed to pay for diagnostic testing and treatment for COVID-19.

CMS issued new guidance Friday to help states implement the new interoperability policies in Medicaid and CHIP programs.

GoodRx has released its latest list of the most expensive drugs in America, with orphan drugs and therapies for rare conditions topping the ranking.